Increased cyclin E level in retinoblastoma cells during programmed cell death

Cell Mol Biol (Noisy-le-grand). 1998 Dec;44(8):1229-35.

Abstract

Camptothecin (an inhibitor of topoisomerase I) and etoposide and amsacrine (inhibitors of topoisomerase II) both capable of triggering programmed cell death in Y79 cells, induced a remarkable dose-dependent increase in the level of cyclin E in these cells. Camptothecin was found to be the most effective compound. The effect was not observed when the cells were treated with other inducers of programmed cell death (C2-ceramide, sodium butyrate, interleukin-1beta and tumor necrosis factor), all of which do not damage DNA. The effect, which was completely prevented by inhibitors of macromolecular synthesis, occurred after a lag phase (12 hrs.) and increased concurrently with the rise in programmed cell death (PCD), reaching a maximum after 36 hrs. of incubation, when a large percentage of cells (95%) showed clear PCD signals. We suggest that cyclin E takes part in the final stage of programmed cell death which is induced by topoisomerase inhibitors in Y79 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amsacrine / metabolism
  • Apoptosis / physiology*
  • Camptothecin / metabolism
  • Cyclin A / drug effects
  • Cyclin A / metabolism
  • Cyclin E / drug effects
  • Cyclin E / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Etoposide / metabolism
  • Humans
  • Interleukin-1
  • Retinoblastoma / metabolism*
  • Retinoblastoma / pathology
  • Sphingosine / analogs & derivatives
  • Sphingosine / metabolism
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cyclin A
  • Cyclin E
  • Enzyme Inhibitors
  • Interleukin-1
  • N-acetylsphingosine
  • Topoisomerase I Inhibitors
  • Topoisomerase II Inhibitors
  • Tumor Necrosis Factor-alpha
  • Amsacrine
  • Etoposide
  • Sphingosine
  • Camptothecin